Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Delignat

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Haematologica|November 18, 2017
Complement C3 is a novel modulator of the anti-factor VIII immune responseJulie Rayes, Mathieu Ing, Sandrine Delignat, et al.
Blood|November 6, 2009
Induction of heme oxygenase-1 in factor VIII-deficient mice reduces the immune response to therapeutic factor VIIIJordan D Dimitrov, Suryasarathi Dasgupta, Ana-Maria Navarrete, et al.
Journal of Neurology|June 17, 2005
Intravenous immunoglobulin in neurological disorders: a mechanistic perspectiveNamita Misra, Jagadeesh Bayry, Amal Ephrem, et al.
Immunology Letters|September 6, 2006
Comparative study of the anti-inflammatory effect of two intravenous immunoglobulin preparations manufactured by different processesSriramulu Elluru, Jean-Paul Duong Van Huyen, Fabienne Prost, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIIISébastien Lacroix-Desmazes, Bharath Wootla, Suryasarathi Dasgupta, et al.
International Immunopharmacology|March 1, 2006
Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanismsJagadeesh Bayry, Jagadeesh Bayary, Sooryasarathi Dasgupta, et al.
Clinical Reviews in Allergy & Immunology|January 5, 2006
Intravenous immunoglobulin and dendritic cellsNamita Misra, Jagadeesh Bayry, Jagadeesh Bayary, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumabMelissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2004
Natural antibodies sustain differentiation and maturation of human dendritic cellsJagadeesh Bayry, Sébastien Lacroix-Desmazes, Vladimira Donkova-Petrini, et al.
Journal of Thrombosis and Haemostasis : JTH|February 7, 2024
High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitroRohini Sekar, Angelina Mimoun, Melissa Bou-Jaoudeh, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Haematologica|November 18, 2017
Complement C3 is a novel modulator of the anti-factor VIII immune responseJulie Rayes, Mathieu Ing, Sandrine Delignat, et al.
Blood|November 6, 2009
Induction of heme oxygenase-1 in factor VIII-deficient mice reduces the immune response to therapeutic factor VIIIJordan D Dimitrov, Suryasarathi Dasgupta, Ana-Maria Navarrete, et al.
Journal of Neurology|June 17, 2005
Intravenous immunoglobulin in neurological disorders: a mechanistic perspectiveNamita Misra, Jagadeesh Bayry, Amal Ephrem, et al.
Immunology Letters|September 6, 2006
Comparative study of the anti-inflammatory effect of two intravenous immunoglobulin preparations manufactured by different processesSriramulu Elluru, Jean-Paul Duong Van Huyen, Fabienne Prost, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIIISébastien Lacroix-Desmazes, Bharath Wootla, Suryasarathi Dasgupta, et al.
International Immunopharmacology|March 1, 2006
Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanismsJagadeesh Bayry, Jagadeesh Bayary, Sooryasarathi Dasgupta, et al.
Clinical Reviews in Allergy & Immunology|January 5, 2006
Intravenous immunoglobulin and dendritic cellsNamita Misra, Jagadeesh Bayry, Jagadeesh Bayary, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumabMelissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2004
Natural antibodies sustain differentiation and maturation of human dendritic cellsJagadeesh Bayry, Sébastien Lacroix-Desmazes, Vladimira Donkova-Petrini, et al.
Journal of Thrombosis and Haemostasis : JTH|February 7, 2024
High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitroRohini Sekar, Angelina Mimoun, Melissa Bou-Jaoudeh, et al.
Pageof 7